Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1-naphthyl isothiocyanate | increases expression | ISO | Arhgap19 (Rattus norvegicus) | 6480464 | 1-Naphthylisothiocyanate results in increased expression of ARHGAP19 mRNA | CTD | PMID:30723492 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | ARHGAP19 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ARHGAP19 mRNA | CTD | PMID:20106945 and PMID:21632981 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Arhgap19 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ARHGAP19 mRNA | CTD | PMID:32109520 and PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | ARHGAP19 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ARHGAP19 mRNA | CTD | PMID:22574217 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of ARHGAP19 mRNA | CTD | PMID:21570461 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Arhgap19 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ARHGAP19 mRNA | CTD | PMID:36041667 | acrolein | multiple interactions | ISO | ARHGAP19 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ARHGAP19 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ARHGAP19 mRNA | CTD | PMID:32699268 | Aflatoxin B2 alpha | affects methylation | ISO | ARHGAP19 (Homo sapiens) | 6480464 | aflatoxin B2 affects the methylation of ARHGAP19 intron | CTD | PMID:30157460 | alpha-pinene | multiple interactions | ISO | ARHGAP19 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ARHGAP19 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ARHGAP19 mRNA | CTD | PMID:32699268 | aristolochic acid A | decreases expression | ISO | ARHGAP19 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of ARHGAP19 mRNA | CTD | PMID:33212167 | arsane | affects methylation | ISO | ARHGAP19 (Homo sapiens) | 6480464 | Arsenic affects the methylation of ARHGAP19 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | ARHGAP19 (Homo sapiens) | 6480464 | Arsenic affects the methylation of ARHGAP19 gene | CTD | PMID:25304211 | arsenous acid | increases response to substance | ISO | ARHGAP19 (Homo sapiens) | 6480464 | ARHGAP19 protein results in increased susceptibility to Arsenic Trioxide | CTD | PMID:20707922 | atrazine | increases expression | ISO | ARHGAP19 (Homo sapiens) | 6480464 | Atrazine results in increased expression of ARHGAP19 mRNA | CTD | PMID:22378314 | benzene | decreases expression | ISO | ARHGAP19 (Homo sapiens) | 6480464 | Benzene results in decreased expression of ARHGAP19 mRNA | CTD | PMID:21843810 | benzo[a]pyrene | affects methylation | ISO | ARHGAP19 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of ARHGAP19 intron | CTD | PMID:30157460 | benzo[e]pyrene | increases methylation | ISO | ARHGAP19 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of ARHGAP19 intron | CTD | PMID:30157460 | bisphenol A | decreases expression | ISO | ARHGAP19 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of ARHGAP19 mRNA | CTD | PMID:29275510 | bisphenol A | multiple interactions | ISO | Arhgap19 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ARHGAP19 mRNA | CTD | PMID:36041667 | bisphenol F | multiple interactions | ISO | Arhgap19 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ARHGAP19 mRNA | CTD | PMID:36041667 | bromobenzene | decreases expression | ISO | Arhgap19 (Rattus norvegicus) | 6480464 | bromobenzene results in decreased expression of ARHGAP19 mRNA | CTD | PMID:32479839 | cadmium atom | decreases expression | ISO | ARHGAP19 (Homo sapiens) | 6480464 | Cadmium results in decreased expression of ARHGAP19 mRNA | CTD | PMID:24376830 | cadmium atom | multiple interactions | ISO | ARHGAP19 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARHGAP19 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | ARHGAP19 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARHGAP19 mRNA | CTD | PMID:35301059 | calcitriol | multiple interactions | ISO | ARHGAP19 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of ARHGAP19 mRNA | CTD | PMID:21592394 | calcitriol | decreases expression | ISO | ARHGAP19 (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of ARHGAP19 mRNA | CTD | PMID:21592394 | carbamazepine | affects expression | ISO | ARHGAP19 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of ARHGAP19 mRNA | CTD | PMID:25979313 | carbon nanotube | increases expression | EXP | | 6480464 | Nanotubes and Carbon analog results in increased expression of ARHGAP19 mRNA | CTD | PMID:21624382 | CGP 52608 | multiple interactions | ISO | ARHGAP19 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ARHGAP19 gene] | CTD | PMID:28238834 | chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of ARHGAP19 mRNA | CTD | PMID:37019170 | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of ARHGAP19 mRNA | CTD | PMID:25270620 | coumestrol | increases expression | ISO | ARHGAP19 (Homo sapiens) | 6480464 | Coumestrol results in increased expression of ARHGAP19 mRNA | CTD | PMID:19167446 | diarsenic trioxide | increases response to substance | ISO | ARHGAP19 (Homo sapiens) | 6480464 | ARHGAP19 protein results in increased susceptibility to Arsenic Trioxide | CTD | PMID:20707922 | dioxygen | decreases expression | EXP | | 6480464 | Oxygen deficiency results in decreased expression of ARHGAP19 mRNA | CTD | PMID:20880076 | dorsomorphin | multiple interactions | ISO | ARHGAP19 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | formaldehyde | decreases expression | ISO | ARHGAP19 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of ARHGAP19 mRNA | CTD | PMID:23649840 | lipopolysaccharide | decreases expression | EXP | | 6480464 | Lipopolysaccharides results in decreased expression of ARHGAP19 mRNA | CTD | PMID:26582142 | methapyrilene | increases methylation | ISO | ARHGAP19 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of ARHGAP19 intron | CTD | PMID:30157460 | methyl methanesulfonate | decreases expression | ISO | ARHGAP19 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of ARHGAP19 mRNA | CTD | PMID:23649840 | mitomycin C | decreases expression | EXP | | 6480464 | Mitomycin results in decreased expression of ARHGAP19 mRNA | CTD | PMID:25270620 | N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of ARHGAP19 mRNA | CTD | PMID:17942915 | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ARHGAP19 mRNA] | CTD | PMID:17942915 | ozone | multiple interactions | ISO | ARHGAP19 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ARHGAP19 mRNA more ... | CTD | PMID:32699268 | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of ARHGAP19 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of ARHGAP19 mRNA | CTD | PMID:34911549 | paracetamol | increases expression | ISO | ARHGAP19 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of ARHGAP19 mRNA | CTD | PMID:22230336 | paracetamol | decreases expression | ISO | Arhgap19 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of ARHGAP19 mRNA | CTD | PMID:33387578 | paracetamol | decreases expression | ISO | ARHGAP19 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of ARHGAP19 mRNA | CTD | PMID:29067470 | phenylmercury acetate | decreases expression | ISO | ARHGAP19 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of ARHGAP19 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | ARHGAP19 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGAP19 mRNA | CTD | PMID:27188386 | quercetin | decreases expression | ISO | ARHGAP19 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of ARHGAP19 mRNA | CTD | PMID:21632981 | rotenone | decreases expression | ISO | Arhgap19 (Rattus norvegicus) | 6480464 | Rotenone results in decreased expression of ARHGAP19 mRNA | CTD | PMID:28374803 | SB 431542 | multiple interactions | ISO | ARHGAP19 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sunitinib | decreases expression | ISO | ARHGAP19 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of ARHGAP19 mRNA | CTD | PMID:31533062 | testosterone | multiple interactions | ISO | ARHGAP19 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of ARHGAP19 mRNA | CTD | PMID:21592394 | testosterone | decreases expression | ISO | ARHGAP19 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of ARHGAP19 mRNA | CTD | PMID:21592394 | tetrachloroethene | increases expression | EXP | | 6480464 | Tetrachloroethylene results in increased expression of ARHGAP19 mRNA | CTD | PMID:28973375 | tetrachloromethane | decreases expression | ISO | Arhgap19 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in decreased expression of ARHGAP19 mRNA | CTD | PMID:31150632 | thioacetamide | increases expression | ISO | Arhgap19 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of ARHGAP19 mRNA | CTD | PMID:34492290 | trichloroethene | decreases expression | ISO | Arhgap19 (Rattus norvegicus) | 6480464 | Trichloroethylene results in decreased expression of ARHGAP19 mRNA | CTD | PMID:33387578 | trichostatin A | decreases expression | ISO | ARHGAP19 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of ARHGAP19 mRNA | CTD | PMID:26272509 | trichostatin A | multiple interactions | ISO | ARHGAP19 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ARHGAP19 mRNA | CTD | PMID:27188386 | trovafloxacin | decreases expression | EXP | | 6480464 | trovafloxacin results in decreased expression of ARHGAP19 mRNA | CTD | PMID:35537566 | valproic acid | affects expression | ISO | ARHGAP19 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of ARHGAP19 mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | ISO | ARHGAP19 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of ARHGAP19 mRNA | CTD | PMID:23179753 and PMID:27188386 | zoledronic acid | decreases expression | ISO | ARHGAP19 (Homo sapiens) | 6480464 | zoledronic acid results in decreased expression of ARHGAP19 mRNA | CTD | PMID:20977926 | |